New nordihydroguaiaretic acid derivatives as anti-HIV agents

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 6, 2008, Pages 1884-1888

  Hwu, Jih Ru ^a,b   Hsu, Ming Hua ^a,c   Huang, Ru Chih C ^c  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti HIV; DNA; HIV Tat regulated transactivation; NDGA; Nordihydroguaiaretic acid

Indexed keywords

1 PIPERIDINECARBONYL CHLORIDE; 1,1,1 TRICHLOROETHANE; 2,3 DIMETHYL 1,4 BIS[3,4 [2 (PIPERDINO)ETHOXYPHENYL]]BUTANE TETRAKISHYDROCHLORIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARBAMIC ACID; CARBONIC ACID; CARBONYLDIIMIDAZOLE; CHLORINE DERIVATIVE; CHLOROFORMIC ACID METHYL ESTER; IMIDAZOLE DERIVATIVE; NITROGEN DERIVATIVE; NORDIHYDROGUAIARETIC ACID; PHENOL DERIVATIVE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; MOLECULAR STABILITY; PRODUCT RECOVERY; SOLUBILITY; TRANSACTIVATION;

ALKALINE PHOSPHATASE; ANIMALS; ANTI-HIV AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOMEGALOVIRUS; DNA, VIRAL; HUMANS; MOLECULAR STRUCTURE; NORDIHYDROGUAIARETIC ACID; PIPERIDINES; PLASMIDS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANS-ACTIVATION (GENETICS);

EID: 40749139875     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2008.02.018     Document Type: Article

References (24)

1. Trang T., Stutak M., Quirion R., and Jhamandas K. Br. J. Pharmacol. 140 (2003) 295
2. Nakadate T. Jpn. J. Pharmacol. 49 (1989) 1
3. Hausott B., Greger H., and Marian B. J. Cancer Res. Clin. Oncol. 129 (2003) 569
4. Fujiwara T., Misumi Y., and Ikehara Y. Biochem. Biophys. Res. Commun. 301 (2003) 927
5. Cheng J.S., and Jan C.R. Toxicol. In Vitro 16 (2002) 485
6. Huang J.K., Chen W.C., Huang C.J., Hsu S.S., Chen J.S., Cheng H.H., Chang H.T., Jiann B.P., and Jan C.R. Life Sci. 75 (2004) 2341
7. Yamamura H., Nagano N., Hirano M., Muraki K., Watanabe M., and Imaizumi Y. J. Pharmacol. Exp. Ther. 291 (1999) 140
8. Ono K., Hasegawa K., Yoshiike Y., Takashima A., Yamada M., and Naiki H. J. Neurochem. 81 (2002) 434
9. Lee C.H., Jang Y.S., Her S.J., Moon Y.M., Baek S.J., and Eling T. Exp. Cell. Res. 289 (2003) 335
10. Hwu J.R., Tseng W.N., Gnabre J., Giza P., and Huang R.C. J. Med. Chem. 41 (1998) 2994
11. Huang R.C., Li Y., Giza P.E., Gnabre J.N., Abd-Elazem I.S., King K.Y., and Hwu J.R. Antiviral Res. 58 (2003) 57
12. King K.Y., Hakimelahi G.H., Huang R.C., and Hwu J.R. J. Genetics Mol. Biol. 13 (2002) 248
13. Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., and Huang R.C. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11239
14. Gnabre J., Ito Y., Ma Y., and Huang R.C. J. Chromatogr. A 719 (1996) 353
15. Chen H., Teng L., Li J., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N., and Huang R.C. J. Med. Chem. 41 (1998) 3001
16. Park R., Giza P.E., Mold D.E., and Huang R.C. Antiviral Res. 58 (2003) 35
17. Craigol J., Callahan M., Huang R.C., and DeLucia A. Antiviral Res. 47 (2000) 19
18. Chang C.-C., Heller J.D., Kuo J., and Huang R.C. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13239
19. Heller J.D., Kuo J., Wu T.C., Kast W.M., and Huang R.C. Cancer Res. 61 (2001) 5499
20. Arya S.K., Guo C., Josephs S.F., and Wong-Staal F. Science 229 (1985) 69
21. Hsu M.C., Schutt A.D., Holly M., Slice L.W., Sherman M.I., Richman D.D., Potash M.J., and Volsky D.J. Science 254 (1991) 1799
22. Berger J., Hauber J., Hauber R., Geiger R., and Cullen B. Gene 66 (1988) 1
23. Ducki S., Hadfield J.A., Hepworth L.A., Lawrence N.J., Liu C.Y., and McGown A.T. Bioorg. Med. Chem. Lett. 7 (1997) 3091
24. Sjøttem E., Andersen C., and Johansen T. J. Mol. Biol. 267 (1997) 490